Orthofix To Present New Data, Highlight New Products and Sponsor Events at NASS Annual Meeting
LEWISVILLE, Texas — September 23, 2024 — Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced the presentation of new data supporting the use of Orthofix’s proprietary Pulsed Electromagnetic Field (PEMF) stimulation to increase fusion rates as an adjunct to lumbar spine fusion surgery. Patients treated with the SpinalStim™ bone growth therapy device demonstrated a high rate of successful fusion with significant improvements in pain, function and quality of life, despite having risk factors for pseudarthrosis.
The abstract will be presented by Dr. Marc Weinstein, an orthopedic spine surgeon at the Florida Orthopaedic Institute in Tampa, Florida, at the North American Spine Society (NASS) Annual Meeting in Chicago, IL, on September 25, during the Research and Innovation Showcase in the McCormick Place West Lobby of the McCormick Convention Center.
During the NASS annual meeting, Orthofix is also highlighting a variety of new products including the full market launch of OsteoStrand™ Plus C. A 100% bone-derived graft, OsteoStrand Plus C is comprised of Demineralized Bone Matrix (DBM) fibers and Accell™ Bone Matrix, a dispersed form of DBM that provides immediate release of growth factors upon implantation and increases the concentration of growth factors in the product, and cancellous chips. Used as a bone graft material in fusion applications, the OsteoStrand Plus C features improved graft packability relative to non-chip containing options – for a denser fill and to ensure minimal graft displacement. Additionally, Orthofix is announcing the launch of the M6-C™ Single-Use, Disposable Instrumentation sets, the first FDA-cleared, single-use, disposable instruments designed specifically for cervical disc arthroplasty.
Orthofix Sponsored Events
Orthofix will be sponsoring opportunities to learn more about the 7D FLASH™ Navigation System through an educational dinner with Dr. Jason McGowan and Dr. Amir Vokshoor. Additionally, the company is offering an educational dinner for surgeons to learn more about optimizing fusion through identifying the right combination of interbody surface technology, data-driven biologics, and bone growth therapies with Dr. Raymond Hah and Dr. James Bruffey.
Those attending NASS can learn more about these events and Orthofix’s portfolio of spine solutions by visiting booth #3017.